Charles River Laboratories International Inc.

Charles River Laboratories International Inc.

CRL

Market Cap$6.82B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Charles River Laboratories International Inc.Charles River Laboratories International Inc.564.1-0%1.80.9
$149.46

Current Fair Value

3.8% upside

Undervalued by 3.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.82 Billion
Enterprise Value$9.59 Billion
Dividend Yield$0 (0%)
Earnings per Share$0.67
Beta1.5
Outstanding Shares51,138,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio564.09
PEG-263.29
Price to Sales1.82
Price to Book Ratio2.12
Enterprise Value to Revenue2.37
Enterprise Value to EBIT70.92
Enterprise Value to Net Income725
Total Debt to Enterprise0.31
Debt to Equity0.86

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Charles River Laboratories International Inc.

17,000 employees
CEO: James Foster

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our...